Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome
Low-dose methotrexate is widely used in mycosis fungoides and Sézary syndrome, but few studies have evaluated this treatment. The aim of this study was to evaluate the benefit/risk ratio of this regimen on skin lesions. A retrospective survey of a series of patients treated for mycosis fungoides or...
Main Authors: | Fawaz Alenezi, Céline Girard, Didier Bessis, Bernard Guillot, Aurélie Du-Thanh, Olivier Dereure |
---|---|
Format: | Article |
Language: | English |
Published: |
Society for Publication of Acta Dermato-Venereologica
2021-02-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3719
|
Similar Items
-
The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome
by: Izabela Błażewicz, et al.
Published: (2021-05-01) -
The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome
by: Anne Hald Rittig, et al.
Published: (2019-09-01) -
Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome
by: LG Gorenkova, et al.
Published: (2017-07-01) -
A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
by: Andjela Egger, BS, et al.
Published: (2020-06-01) -
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
by: Nuria García-Díaz, et al.
Published: (2021-04-01)